This is a preview of subscription content, log in via an institution to check access.
Notes
2015 euros
Reference
Radermacher LK, et al. Type I Diabetes Is The Main Cost Driver In Autoimmune Polyendocrinopathy. Journal of Clinical Endocrinology and Metabolism : 16 Sep 2019. Available from: URL: http://doi.org/10.1210/clinem/dgz021
Rights and permissions
About this article
Cite this article
Type 1 diabetes drives costs of autoimmune polyendocrinopathy. PharmacoEcon Outcomes News 838, 30 (2019). https://doi.org/10.1007/s40274-019-6275-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6275-x